Correlation Between AstraZeneca PLC and AB Volvo

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and AB Volvo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and AB Volvo into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC and AB Volvo, you can compare the effects of market volatilities on AstraZeneca PLC and AB Volvo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of AB Volvo. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and AB Volvo.

Diversification Opportunities for AstraZeneca PLC and AB Volvo

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between AstraZeneca and VOLV-B is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and AB Volvo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AB Volvo and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with AB Volvo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AB Volvo has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and AB Volvo go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and AB Volvo

Assuming the 90 days trading horizon AstraZeneca PLC is expected to generate 1.01 times more return on investment than AB Volvo. However, AstraZeneca PLC is 1.01 times more volatile than AB Volvo. It trades about 0.4 of its potential returns per unit of risk. AB Volvo is currently generating about -0.19 per unit of risk. If you would invest  142,600  in AstraZeneca PLC on February 7, 2024 and sell it today you would earn a total of  20,800  from holding AstraZeneca PLC or generate 14.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AstraZeneca PLC  vs.  AB Volvo

 Performance 
       Timeline  
AstraZeneca PLC 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, AstraZeneca PLC unveiled solid returns over the last few months and may actually be approaching a breakup point.
AB Volvo 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AB Volvo are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, AB Volvo may actually be approaching a critical reversion point that can send shares even higher in June 2024.

AstraZeneca PLC and AB Volvo Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and AB Volvo

The main advantage of trading using opposite AstraZeneca PLC and AB Volvo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, AB Volvo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AB Volvo will offset losses from the drop in AB Volvo's long position.
The idea behind AstraZeneca PLC and AB Volvo pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Share Portfolio
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals